LB Pharmaceuticals Inc Common Stock

NASDAQ:LBRX

Biotechnology

Healthcare
$40.06 -1.30%

-$0.39 today

Market cap
$1.30B
Beta
0.71
P/E (TTM)
-21.4
EPS (TTM)
-$1.39
52W Low $13.36High $33.47

Volume 0.36M

Average 0.23M

Balance Sheet

Inspect the capital base behind the business.

Assets

$312.93M

FY 2025 · Annual

+833.2% YoY

Liabilities

$11.62M

FY 2025 · Annual

-90.9% YoY

Equity

$301.31M

FY 2025 · Annual

Balance Sheet

USD
Metric
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents21.4M14.98M22.98M250.17M
Short-term Investments028.31M5.02M45.04M
Net Receivables0000
Inventory0000
Other Current Assets9K26K132K11.24M
Total Current Assets21.49M45.63M28.88M308.43M
Property, Plant & Equipment (Net)3K23K4.16M3.73M
Goodwill0000
Intangible Assets0000
Long-term Investments000770K
Tax Assets0000
Other Non-current Assets00498K0
Total Non-current Assets3K23K4.66M4.5M
Total Assets21.49M45.66M33.53M312.93M
Account Payables156K1.39M2.32M2.13M
Short-term Debt000730K
Tax Payables0000
Deferred Revenue0000
Other Current Liabilities221K798K2.24M2.91M
Total Current Liabilities469K2.61M8.11M7.44M
Long-term Debt24.15M000
Deferred Tax Liabilities0000
Deferred Revenue (Non-current)0000
Other Non-current Liabilities25.69M77.52M116.76M1.34M
Total Non-current Liabilities49.84M77.52M119.98M4.18M
Total Liabilities50.3M80.13M128.09M11.62M
Common Stock1K1K1K3K
Retained Earnings(34.95M)(41.22M)(104.32M)(129.53M)
Accumulated OCI0274K111K168K
Other Stockholders Equity0000
Minority Interest0000
Total Equity(28.81M)(34.47M)(94.55M)301.31M
Total Debt24.15M03.7M3.57M
Net Debt2.74M(14.98M)(19.28M)(246.6M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$320.7M
Short-term Investments$45.0M
Other Current$23.4M
Total Current Assets$389.1M
PP&E (Net)$3.6M
Long-term Investments$776.0K
Total Non-current Assets$4.4M
Total Assets$393.5M

Analysis

Selected assets total $393.5M for Latest. The largest visible component is Cash & Equivalents at $320.7M, about 81.5% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
10-QQuarterly reportNov 5, 2026
8-KCurrent reportNov 5, 2026
4Statement of changes in beneficial ownershipOct 13, 2026
SC 13G/ASC 13G/A filingOct 13, 2026
4Statement of changes in beneficial ownershipOct 13, 2026

How much cash does LBRX have?

LB Pharmaceuticals Inc Common Stock (LBRX) reported $250.17M in cash and equivalents in fiscal 2025.

How much debt does LBRX carry?

LB Pharmaceuticals Inc Common Stock (LBRX) reported $3.57M of total debt, with net debt of -$246.60M.